Journal
SEMINARS IN REPRODUCTIVE MEDICINE
Volume 30, Issue 3, Pages 191-198Publisher
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0032-1311521
Keywords
medically assisted reproduction (MAR); assisted reproductive technology (ART); tissues and cells directive; quality indicators; laboratory; protocol drift; benchmarking
Categories
Ask authors/readers for more resources
Since 2004, assisted conception is encompassed by the European Directive on the Quality and Safety of Tissues and Cells (2004/23/EC). The aim of a standard for quality and safety is to minimize risks of errors, contamination, and accidents and to maximize efficiency of use. This article presents a case study of the implementation of the Tissues and Cells Directive in the Leuven University Fertility Center (LUFC) with a focus on the assisted reproductive technologies laboratory with respect to laboratory facilities, quality management system, traceability, storage conditions as well as serological screening. Although the current European Union (EU) Directive can be considered a step in the right direction to improve patient safety, questions remain as to whether the implementation of this EU Directive, requiring extra time and money, has resulted in higher quality with respect to the quality dimensions of effectiveness, efficiency, timeliness, equity, and patient centeredness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available